[HTML][HTML] Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against …
The ongoing COVID-19 pandemic caused by SARS-CoV-2 infection has threatened global
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS …
HE Jung, KB Ku, BH Kang, JH Park, HC Kim… - Antiviral … - pubmed.ncbi.nlm.nih.gov
The ongoing COVID-19 pandemic caused by SARS-CoV-2 infection has threatened global
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS …
H Jung, K Ku, B Kang, J Park, H Kim, K Kim… - Antiviral Research, 2023 - europepmc.org
The ongoing COVID-19 pandemic caused by SARS-CoV-2 infection has threatened global
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS …
HE Jung, KB Ku, BH Kang, JH Park, HC Kim… - Antiviral …, 2023 - pure.kaist.ac.kr
The ongoing COVID-19 pandemic caused by SARS-CoV-2 infection has threatened global
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
[HTML][HTML] Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against …
HE Jung, KB Ku, BH Kang, JH Park, HC Kim… - Antiviral …, 2023 - ncbi.nlm.nih.gov
The ongoing COVID-19 pandemic caused by SARS-CoV-2 infection has threatened global
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS …
HE Jung, KB Ku, BH Kang, JH Park, HC Kim… - Antiviral …, 2023 - europepmc.org
The ongoing COVID-19 pandemic caused by SARS-CoV-2 infection has threatened global
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …
health. Since the first case of infection was reported in December 2019, SARS-CoV-2 has …